Therapeutic market was valued at US$ 74150 million in 2023 and is anticipated to reach US$ 93600 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.

Central Nervous System (CNS) Therapeutic Market

A central nervous system (CNS) disease can affect either the brain or the spinal cord which leads to neurological or psychiatric disorders.

The global Central Nervous System (CNS)

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Central Nervous System (CNS) Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Central Nervous System (CNS) Therapeutic.

Report Scope

The Central Nervous System (CNS) Therapeutic market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Central Nervous System (CNS) Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Central Nervous System (CNS) Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Central Nervous System (CNS) Therapeutic Market Report

Report Metric	Details
Report Name	Central Nervous System (CNS) Therapeutic Market
Accounted market size in 2023	US$ 74150 million
Forecasted market size in 2030	US$ 93600 million
CAGR	3.3%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Neurovascular Trauma Mental Health Degenerative Disorder Infections Cancer
Segment by Application	Clinical Application Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Biogen, Johnson & Johnson, Eli Lilly, Otsuka America Pharmaceutical, Merck, Astrazeneca, Novartis, Teva Pharmaceutical Industries, Takeda
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Central Nervous System (CNS) Therapeutic companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Central Nervous System (CNS) Therapeutic Market growing?

Ans: The Central Nervous System (CNS) Therapeutic Market witnessing a CAGR of 3.3% during the forecast period 2024-2030.

What is the Central Nervous System (CNS) Therapeutic Market size in 2030?

Ans: The Central Nervous System (CNS) Therapeutic Market size in 2030 will be US$ 93600 million.

Who are the main players in the Central Nervous System (CNS) Therapeutic Market report?

Ans: The main players in the Central Nervous System (CNS) Therapeutic Market are Pfizer, Biogen, Johnson & Johnson, Eli Lilly, Otsuka America Pharmaceutical, Merck, Astrazeneca, Novartis, Teva Pharmaceutical Industries, Takeda

What are the Application segmentation covered in the Central Nervous System (CNS) Therapeutic Market report?

Ans: The Applications covered in the Central Nervous System (CNS) Therapeutic Market report are Clinical Application, Others

What are the Type segmentation covered in the Central Nervous System (CNS) Therapeutic Market report?

Ans: The Types covered in the Central Nervous System (CNS) Therapeutic Market report are Neurovascular, Trauma, Mental Health, Degenerative Disorder, Infections, Cancer

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Neurovascular

1.2.3 Trauma

1.2.4 Mental Health

1.2.5 Degenerative Disorder

1.2.6 Infections

1.2.7 Cancer

1.3 Market by Application

1.3.1 Global Central Nervous System (CNS) Therapeutic Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Clinical Application

1.3.3 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Central Nervous System (CNS) Therapeutic Market Perspective (2019-2030)

2.2 Central Nervous System (CNS) Therapeutic Growth Trends by Region

2.2.1 Global Central Nervous System (CNS) Therapeutic Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Central Nervous System (CNS) Therapeutic Historic Market Size by Region (2019-2024)

2.2.3 Central Nervous System (CNS) Therapeutic Forecasted Market Size by Region (2025-2030)

2.3 Central Nervous System (CNS) Therapeutic Market Dynamics

2.3.1 Central Nervous System (CNS) Therapeutic Industry Trends

2.3.2 Central Nervous System (CNS) Therapeutic Market Drivers

2.3.3 Central Nervous System (CNS) Therapeutic Market Challenges

2.3.4 Central Nervous System (CNS) Therapeutic Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Central Nervous System (CNS) Therapeutic Players by Revenue

3.1.1 Global Top Central Nervous System (CNS) Therapeutic Players by Revenue (2019-2024)

3.1.2 Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Players (2019-2024)

3.2 Global Central Nervous System (CNS) Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Central Nervous System (CNS) Therapeutic Revenue

3.4 Global Central Nervous System (CNS) Therapeutic Market Concentration Ratio

3.4.1 Global Central Nervous System (CNS) Therapeutic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Central Nervous System (CNS) Therapeutic Revenue in 2023

3.5 Central Nervous System (CNS) Therapeutic Key Players Head office and Area Served

3.6 Key Players Central Nervous System (CNS) Therapeutic Product Solution and Service

3.7 Date of Enter into Central Nervous System (CNS) Therapeutic Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Central Nervous System (CNS) Therapeutic Breakdown Data by Type

4.1 Global Central Nervous System (CNS) Therapeutic Historic Market Size by Type (2019-2024)

4.2 Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Type (2025-2030)

5 Central Nervous System (CNS) Therapeutic Breakdown Data by Application

5.1 Global Central Nervous System (CNS) Therapeutic Historic Market Size by Application (2019-2024)

5.2 Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Central Nervous System (CNS) Therapeutic Market Size (2019-2030)

6.2 North America Central Nervous System (CNS) Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Central Nervous System (CNS) Therapeutic Market Size by Country (2019-2024)

6.4 North America Central Nervous System (CNS) Therapeutic Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Central Nervous System (CNS) Therapeutic Market Size (2019-2030)

7.2 Europe Central Nervous System (CNS) Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2019-2024)

7.4 Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size (2019-2030)

8.2 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region (2019-2024)

8.4 Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Central Nervous System (CNS) Therapeutic Market Size (2019-2030)

9.2 Latin America Central Nervous System (CNS) Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2019-2024)

9.4 Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size (2019-2030)

10.2 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country (2019-2024)

10.4 Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Central Nervous System (CNS) Therapeutic Introduction

11.1.4 Pfizer Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024)

11.1.5 Pfizer Recent Development

11.2 Biogen

11.2.1 Biogen Company Detail

11.2.2 Biogen Business Overview

11.2.3 Biogen Central Nervous System (CNS) Therapeutic Introduction

11.2.4 Biogen Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024)

11.2.5 Biogen Recent Development

11.3 Johnson & Johnson

11.3.1 Johnson & Johnson Company Detail

11.3.2 Johnson & Johnson Business Overview

11.3.3 Johnson & Johnson Central Nervous System (CNS) Therapeutic Introduction

11.3.4 Johnson & Johnson Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024)

11.3.5 Johnson & Johnson Recent Development

11.4 Eli Lilly

11.4.1 Eli Lilly Company Detail

11.4.2 Eli Lilly Business Overview

11.4.3 Eli Lilly Central Nervous System (CNS) Therapeutic Introduction

11.4.4 Eli Lilly Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024)

11.4.5 Eli Lilly Recent Development

11.5 Otsuka America Pharmaceutical

11.5.1 Otsuka America Pharmaceutical Company Detail

11.5.2 Otsuka America Pharmaceutical Business Overview

11.5.3 Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Introduction

11.5.4 Otsuka America Pharmaceutical Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024)

11.5.5 Otsuka America Pharmaceutical Recent Development

11.6 Merck

11.6.1 Merck Company Detail

11.6.2 Merck Business Overview

11.6.3 Merck Central Nervous System (CNS) Therapeutic Introduction

11.6.4 Merck Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024)

11.6.5 Merck Recent Development

11.7 Astrazeneca

11.7.1 Astrazeneca Company Detail

11.7.2 Astrazeneca Business Overview

11.7.3 Astrazeneca Central Nervous System (CNS) Therapeutic Introduction

11.7.4 Astrazeneca Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024)

11.7.5 Astrazeneca Recent Development

11.8 Novartis

11.8.1 Novartis Company Detail

11.8.2 Novartis Business Overview

11.8.3 Novartis Central Nervous System (CNS) Therapeutic Introduction

11.8.4 Novartis Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024)

11.8.5 Novartis Recent Development

11.9 Teva Pharmaceutical Industries

11.9.1 Teva Pharmaceutical Industries Company Detail

11.9.2 Teva Pharmaceutical Industries Business Overview

11.9.3 Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Introduction

11.9.4 Teva Pharmaceutical Industries Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024)

11.9.5 Teva Pharmaceutical Industries Recent Development

11.10 Takeda

11.10.1 Takeda Company Detail

11.10.2 Takeda Business Overview

11.10.3 Takeda Central Nervous System (CNS) Therapeutic Introduction

11.10.4 Takeda Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024)

11.10.5 Takeda Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Otsuka America Pharmaceutical

Merck

Astrazeneca plc

Novartis

Teva Pharmaceutical Industries

Takeda

List of Tables

Table 1. Global Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Neurovascular

Table 3. Key Players of Trauma

Table 4. Key Players of Mental Health

Table 5. Key Players of Degenerative Disorder

Table 6. Key Players of Infections

Table 7. Key Players of Cancer

Table 8. Global Central Nervous System (CNS) Therapeutic Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Central Nervous System (CNS) Therapeutic Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 10. Global Central Nervous System (CNS) Therapeutic Market Size by Region (2019-2024) & (US$ Million)

Table 11. Global Central Nervous System (CNS) Therapeutic Market Share by Region (2019-2024)

Table 12. Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 13. Global Central Nervous System (CNS) Therapeutic Market Share by Region (2025-2030)

Table 14. Central Nervous System (CNS) Therapeutic Market Trends

Table 15. Central Nervous System (CNS) Therapeutic Market Drivers

Table 16. Central Nervous System (CNS) Therapeutic Market Challenges

Table 17. Central Nervous System (CNS) Therapeutic Market Restraints

Table 18. Global Central Nervous System (CNS) Therapeutic Revenue by Players (2019-2024) & (US$ Million)

Table 19. Global Central Nervous System (CNS) Therapeutic Market Share by Players (2019-2024)

Table 20. Global Top Central Nervous System (CNS) Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System (CNS) Therapeutic as of 2023)

Table 21. Ranking of Global Top Central Nervous System (CNS) Therapeutic Companies by Revenue (US$ Million) in 2023

Table 22. Global 5 Largest Players Market Share by Central Nervous System (CNS) Therapeutic Revenue (CR5 and HHI) & (2019-2024)

Table 23. Key Players Headquarters and Area Served

Table 24. Key Players Central Nervous System (CNS) Therapeutic Product Solution and Service

Table 25. Date of Enter into Central Nervous System (CNS) Therapeutic Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Central Nervous System (CNS) Therapeutic Market Size by Type (2019-2024) & (US$ Million)

Table 28. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Type (2019-2024)

Table 29. Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 30. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Type (2025-2030)

Table 31. Global Central Nervous System (CNS) Therapeutic Market Size by Application (2019-2024) & (US$ Million)

Table 32. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Application (2019-2024)

Table 33. Global Central Nervous System (CNS) Therapeutic Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 34. Global Central Nervous System (CNS) Therapeutic Revenue Market Share by Application (2025-2030)

Table 35. North America Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. North America Central Nervous System (CNS) Therapeutic Market Size by Country (2019-2024) & (US$ Million)

Table 37. North America Central Nervous System (CNS) Therapeutic Market Size by Country (2025-2030) & (US$ Million)

Table 38. Europe Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2019-2024) & (US$ Million)

Table 40. Europe Central Nervous System (CNS) Therapeutic Market Size by Country (2025-2030) & (US$ Million)

Table 41. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 42. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region (2019-2024) & (US$ Million)

Table 43. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size by Region (2025-2030) & (US$ Million)

Table 44. Latin America Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2019-2024) & (US$ Million)

Table 46. Latin America Central Nervous System (CNS) Therapeutic Market Size by Country (2025-2030) & (US$ Million)

Table 47. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 48. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size by Country (2025-2030) & (US$ Million)

Table 50. Pfizer Company Detail

Table 51. Pfizer Business Overview

Table 52. Pfizer Central Nervous System (CNS) Therapeutic Product

Table 53. Pfizer Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024) & (US$ Million)

Table 54. Pfizer Recent Development

Table 55. Biogen Company Detail

Table 56. Biogen Business Overview

Table 57. Biogen Central Nervous System (CNS) Therapeutic Product

Table 58. Biogen Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024) & (US$ Million)

Table 59. Biogen Recent Development

Table 60. Johnson & Johnson Company Detail

Table 61. Johnson & Johnson Business Overview

Table 62. Johnson & Johnson Central Nervous System (CNS) Therapeutic Product

Table 63. Johnson & Johnson Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024) & (US$ Million)

Table 64. Johnson & Johnson Recent Development

Table 65. Eli Lilly Company Detail

Table 66. Eli Lilly Business Overview

Table 67. Eli Lilly Central Nervous System (CNS) Therapeutic Product

Table 68. Eli Lilly Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024) & (US$ Million)

Table 69. Eli Lilly Recent Development

Table 70. Otsuka America Pharmaceutical Company Detail

Table 71. Otsuka America Pharmaceutical Business Overview

Table 72. Otsuka America Pharmaceutical Central Nervous System (CNS) Therapeutic Product

Table 73. Otsuka America Pharmaceutical Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024) & (US$ Million)

Table 74. Otsuka America Pharmaceutical Recent Development

Table 75. Merck Company Detail

Table 76. Merck Business Overview

Table 77. Merck Central Nervous System (CNS) Therapeutic Product

Table 78. Merck Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024) & (US$ Million)

Table 79. Merck Recent Development

Table 80. Astrazeneca Company Detail

Table 81. Astrazeneca Business Overview

Table 82. Astrazeneca Central Nervous System (CNS) Therapeutic Product

Table 83. Astrazeneca Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024) & (US$ Million)

Table 84. Astrazeneca Recent Development

Table 85. Novartis Company Detail

Table 86. Novartis Business Overview

Table 87. Novartis Central Nervous System (CNS) Therapeutic Product

Table 88. Novartis Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024) & (US$ Million)

Table 89. Novartis Recent Development

Table 90. Teva Pharmaceutical Industries Company Detail

Table 91. Teva Pharmaceutical Industries Business Overview

Table 92. Teva Pharmaceutical Industries Central Nervous System (CNS) Therapeutic Product

Table 93. Teva Pharmaceutical Industries Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024) & (US$ Million)

Table 94. Teva Pharmaceutical Industries Recent Development

Table 95. Takeda Company Detail

Table 96. Takeda Business Overview

Table 97. Takeda Central Nervous System (CNS) Therapeutic Product

Table 98. Takeda Revenue in Central Nervous System (CNS) Therapeutic Business (2019-2024) & (US$ Million)

Table 99. Takeda Recent Development

Table 100. Research Programs/Design for This Report

Table 101. Key Data Information from Secondary Sources

Table 102. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Central Nervous System (CNS) Therapeutic Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Central Nervous System (CNS) Therapeutic Market Share by Type: 2023 VS 2030

Figure 3. Neurovascular Features

Figure 4. Trauma Features

Figure 5. Mental Health Features

Figure 6. Degenerative Disorder Features

Figure 7. Infections Features

Figure 8. Cancer Features

Figure 9. Global Central Nervous System (CNS) Therapeutic Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 10. Global Central Nervous System (CNS) Therapeutic Market Share by Application: 2023 VS 2030

Figure 11. Clinical Application Case Studies

Figure 12. Others Case Studies

Figure 13. Central Nervous System (CNS) Therapeutic Report Years Considered

Figure 14. Global Central Nervous System (CNS) Therapeutic Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Central Nervous System (CNS) Therapeutic Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Central Nervous System (CNS) Therapeutic Market Share by Region: 2023 VS 2030

Figure 17. Global Central Nervous System (CNS) Therapeutic Market Share by Players in 2023

Figure 18. Global Top Central Nervous System (CNS) Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Central Nervous System (CNS) Therapeutic as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Central Nervous System (CNS) Therapeutic Revenue in 2023

Figure 20. North America Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Central Nervous System (CNS) Therapeutic Market Share by Country (2019-2030)

Figure 22. United States Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Central Nervous System (CNS) Therapeutic Market Share by Country (2019-2030)

Figure 26. Germany Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Central Nervous System (CNS) Therapeutic Market Share by Region (2019-2030)

Figure 34. China Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Central Nervous System (CNS) Therapeutic Market Share by Country (2019-2030)

Figure 42. Mexico Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Central Nervous System (CNS) Therapeutic Market Share by Country (2019-2030)

Figure 46. Turkey Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Central Nervous System (CNS) Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Pfizer Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2019-2024)

Figure 49. Biogen Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2019-2024)

Figure 50. Johnson & Johnson Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2019-2024)

Figure 51. Eli Lilly Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2019-2024)

Figure 52. Otsuka America Pharmaceutical Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2019-2024)

Figure 53. Merck Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2019-2024)

Figure 54. Astrazeneca Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2019-2024)

Figure 55. Novartis Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2019-2024)

Figure 56. Teva Pharmaceutical Industries Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2019-2024)

Figure 57. Takeda Revenue Growth Rate in Central Nervous System (CNS) Therapeutic Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-20G14329

Thu May 02 00:00:00 UTC 2024

Add to Cart

Global Nocturia Treatment Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-39M10215

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Medicine Treat BPH Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-33F12613

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Neurorehabilitation Gaming Systems Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-38E10017

Sun Apr 28 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Central Nervous System (CNS) Therapeutic Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-13R14174

Global Central Nervous System (CNS) Therapeutic Market Research Report 2024

FEATURED COMPANIES

Central Nervous System (CNS) Therapeutic Market Size

Central Nervous System (CNS) Therapeutic Market

Report Scope

Scope of Central Nervous System (CNS) Therapeutic Market Report

Chapter Outline

FAQ for this report

How fast is Central Nervous System (CNS) Therapeutic Market growing?

What is the Central Nervous System (CNS) Therapeutic Market size in 2030?

Who are the main players in the Central Nervous System (CNS) Therapeutic Market report?

What are the Application segmentation covered in the Central Nervous System (CNS) Therapeutic Market report?

What are the Type segmentation covered in the Central Nervous System (CNS) Therapeutic Market report?

FEATURED COMPANIES

RELATED REPORTS